InvestorsHub Logo
Followers 20
Posts 5368
Boards Moderated 0
Alias Born 01/04/2012

Re: None

Monday, 01/23/2012 4:05:27 AM

Monday, January 23, 2012 4:05:27 AM

Post# of 26138
Please explain to me why many investors ignore the Cancer Research value of BIOSANTE. This link lays it out pretty well.

Cancer Vaccine

I took the time to look at a number of biotech companies focusing strictly on cancer research. Unless I am missing something the cancer research portion of the company alone should be worth over $1.50 /share.

Definitely the Rodney Dangerfield of the industry. NO RESPECT!

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.